Analysis of the Peri-Operative Cost of Non-Traumatic Major Lower Extremity Amputation in Jordan

References

• Jordan RW, Marks A, Higman D. The cost of major lower limb amputation: a 12-year experience. Prosthet Orthot Int. 2012;36(4):430–434. doi:10.1177/0309364612441489
   PubMed Web of Science ®Google Scholar
• Boulton AJM, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005;366(9498):1719–1724. doi:10.1016/S0140-6736(05)67698-2
   PubMed Web of Science ®Google Scholar
• Frykberg RG, Cook JJ, Simonson DC. Epidemiology and health care cost of diabetic foot problems. In: Veves A, Giurini JM, Guzman RJ, editors. The Diabetic Foot: Medical and Surgical Management. 4th ed. Springer-Humana Press; 2018:3–17.
   Google Scholar
• Peacock JM, Keo HH, Duval S, et al. The incidence and health economic burden of ischemic amputation in Minnesota, 2005–2008. Prev Chronic Dis. 2011;8(6):A141.
   PubMed Web of Science ®Google Scholar
• Elixhauser A, Andrews RM. Profile of inpatient operating room procedures in US hospitals in 2007. Arch Surg. 2010;145(12):1201–1208. doi:10.1001/archsurg.2010.269
   Google Scholar
• Ponticello M, Andersen CA, Marmolejo VL. Limb salvage versus amputation: a closer look at the evidence, costs and long-term outcomes. Podiatry Today. 2016;29(3):30–39.
   Google Scholar
• Barshes NR, Chambers JD, Cohen J, Belkin M. Model to optimize healthcare value in ischemic extremities 1 (MOVIE) study collaborators. Cost-effectiveness in the contemporary management of critical limb ischemia with tissue loss. J Vasc Surg. 2012;56(4):1015–24 e1. doi:10.1016/j.jvs.2012.02.069
   PubMed Web of Science ®Google Scholar
• Dillingham TR, Pezzin LE, Shore AD. Reamputation, mortality, and health care costs among persons with dysvascular lower-limb amputations. Arch Phys Med Rehabil. 2005;86(3):480–486. doi:10.1016/j.apmr.2004.06.072
   PubMed Web of Science ®Google Scholar
• Driver VR, Fabbi M, Lavery LA, Gibbons G. The costs of diabetic foot: the economic case for the limb salvage team. J Vasc Surg. 2010;52(3 Suppl):17S–22S. doi:10.1016/j.jvs.2010.06.003
   Web of Science ®Google Scholar
• O′ Brien J, Ward A, Salas M. Managing diabetic foot ulcers: economic consequences in the USA. Expert Rev Pharmacoecon Outcomes Res. 2003;3(1):25–32. doi:10.1586/14737167.3.1.25
   Google Scholar
• NHS England/Policy/Analytical Service. Programme budgeting finance manual 2012/13. Available from: https://www.networks.nhs.uk/nhs-networks/health-investment-network/documents/2012-13%20Programme%20Budgeting%20Guidance%20documents.zip. Accessed December 2, 2019.
   Google Scholar
• Kerr M; for Diabetes UK. Diabetic foot care in England, an economic case study. 2017. Available from: https://www.evidence.nhs.uk/document?id=1915227&returnUrl=Search%3Fq%3DAmputation%2Bcost&q=Amputation+cost. Accessed December 31, 2019.
   Google Scholar
• Al-Thani H, Sathian B, El-Menyar A. Assessment of healthcare costs of amputation and prosthesis for upper and lower extremities in a Qatari healthcare institution: a retrospective cohort study. BMJ Open. 2019;9:e024963. doi:10.1136/bmjopen-2018-024963
   Web of Science ®Google Scholar
• Ziegler-Graham K, MacKenzie EJ, Ephraim PL, Travison TG, Brookmeyer R. Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehabil. 2008;89(3):422–429. doi:10.1016/j.apmr.2007.11.005
   PubMed Web of Science ®Google Scholar
• Moxey P, Gogalniceanu P, Hinchliffe R, et al. Lower extremity amputations—a review of global variability in incidence. Diabet Med. 2011;28(10):1144–1153. doi:10.1111/dme.2011.28.issue-10
   PubMed Web of Science ®Google Scholar
• Tan JH, Hong CC, Shen L, Tay EY, Lee JK, Nather A. Costs of patients admitted for diabetic foot problems. Ann Acad Med Singapore. 2015;44(12):567–570.
   Web of Science ®Google Scholar
• Davis W, Norman P, Bruce D, Davis T. Predictors, consequences and costs of diabetes-related lower extremity amputation complicating type 2 diabetes: the Fremantle diabetes study. Diabetologia. 2006;49(11):2634–2641. doi:10.1007/s00125-006-0431-0
   PubMed Web of Science ®Google Scholar
• Yin H, Radican L, Kong SX. A study of regional variation in the inpatient cost of lower extremity amputation among patients with diabetes in the United States. J Med Econ. 2013;16(6):820–827.
   Google Scholar
• Yost ML. Cost-benefit analysis of critical limb ischemia in the era of the affordable care act. Endovascular Today. 2014;5:29–36.
   Google Scholar
• World Health Organization. 29th World health assembly. Ninth revision of the International Classification of Diseases; 1976. Available from: https://apps.who.int/iris/handle/10665/93061. Accessed September 27, 2019.
   Google Scholar
• Jeffcoate W, Macfarlane R, Fletcher E. The description and classification of diabetic foot lesions. Diabet Med. 1993;10(7):676–679. doi:10.1111/dme.1993.10.issue-7
   PubMed Web of Science ®Google Scholar
• Turner HC, Lauer JA, Tran BX, Teerawattananon Y, Jit M. Adjusting for inflation and currency changes within health economic studies. Value Health. 2019;22(9):1026–1032. doi:10.1016/j.jval.2019.03.021
   PubMed Web of Science ®Google Scholar
• Lombardo FL, Maggini M, De Bellis A, Seghieri G, Anichini R. Lower extremity amputations in persons with and without diabetes in Italy: 2001–2010. PLoS One. 2014;9(1):e86405. doi:10.1371/journal.pone.0086405
   PubMed Web of Science ®Google Scholar
• Jensen PS, Petersen J, Kirketerp-Møller K, Poulsen I, Andersen O. Progression of disease preceding lower extremity amputation in Denmark: a longitudinal registry study of diagnoses, use of medication and healthcare services 14 years prior to amputation. BMJ Open. 2017;7(11):e016030. doi:10.1136/bmjopen-2017-016030
   Web of Science ®Google Scholar
• Fowkes FGR, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329–1340. doi:10.1016/S0140-6736(13)61249-0
   PubMed Web of Science ®Google Scholar
• Ajlouni K, Khader YS, Batieha A, Ajlouni H, El-Khateeb M. An increase in prevalence of diabetes mellitus in Jordan over 10 years. J Diabetes Complications. 2008;22(5):317–324. doi:10.1016/j.jdiacomp.2007.01.004
   PubMed Web of Science ®Google Scholar
• Cho N, Shaw J, Karuranga S, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–281. doi:10.1016/j.diabres.2018.02.023
   PubMed Web of Science ®Google Scholar
• Gerdtham U-G, Clarke P, Hayes A, Gudbjornsdottir S. Estimating the cost of diabetes mellitus-related events from inpatient admissions in Sweden using administrative hospitalization data. Pharmacoeconomics. 2009;27(1):81–90. doi:10.2165/00019053-200927010-00008
   PubMed Web of Science ®Google Scholar
• Kurichi JE, Vogel WB, Kwong PL, Xie D, Bates BE, Stineman MG. Factors associated with total inpatient costs and length of stay during surgical hospitalization among veterans who underwent lower extremity amputation. Am J Phys Med Rehabil. 2013;92(3):203–214. doi:10.1097/PHM.0b013e31827446eb
   PubMed Web of Science ®Google Scholar
• The Vascular Society of Great Britain and Ireland. A best practice clinical care pathway for major amputation surgery; April 2010. Available from: https://www.vascularsociety.org.uk/_userfiles/pages/files/Resources/Vasc_Soc_Amputation_Paper_V2.pdf. Accessed September 27, 2019.
   Google Scholar
• The National Diabetes Foot Care Audit, 2014–2018. The fourth annual report; May, 2019. Available from: https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-footcare-audit/2014-2018. Accessed September 27, 2019.
   Google Scholar
• NICE guidelines: diabetic foot problems: prevention and management. NICE Guidelines; January 2016. Available from: https://www.nice.org.uk/guidance/ng19/resources/diabetic-foot-problems-prevention-and-management-pdf-1837279828933. Accessed September 27, 2019.
   Google Scholar
• National Confidential Enquiry into Patient Outcome and Death. Lower limb amputation: working together; 2014. Available from: https://www.ncepod.org.uk/2014report2/downloads/WorkingTogetherFullReport.pdf. Accessed September 27, 2019.
   Google Scholar
• Singh S, Evans L, Datta D, Gaines P, Beard J. The costs of managing lower limb-threatening ischaemia. Eur J Vasc Endovasc Surg. 1996;12(3):359–362. doi:10.1016/S1078-5884(96)80257-7
   Web of Science ®Google Scholar
• Johnson B, Evans L, Drury R, Datta D, Morris-Jones W, Beard J. Surgery for limb threatening ischaemia: a reappraisal of the costs and benefits. Eur J Vasc Endovasc Surg. 1995;9(2):181–188. doi:10.1016/S1078-5884(05)80088-7
   Web of Science ®Google Scholar
• Chery J, Semaan E, Darji S, Briggs WT, Yarmush J, D’Ayala M. Impact of regional versus general anesthesia on the clinical outcomes of patients undergoing major lower extremity amputation. Ann Vasc Surg. 2014;28(5):1149–1156. doi:10.1016/j.avsg.2013.07.033
   Web of Science ®Google Scholar
• Moreira CC, Farber A, Kalish JA, et al. The effect of anesthesia type on major lower extremity amputation in functionally impaired elderly patients. J Vasc Surg. 2016;63(3):696–701. doi:10.1016/j.jvs.2015.09.050
   PubMed Web of Science ®Google Scholar